159 related articles for article (PubMed ID: 36212449)
1. Early economic modeling of magnetic resonance image-guided high intensity focused ultrasound compared to radiotherapy for pain palliation of bone metastases.
Simões Corrêa Galendi J; Yeo SY; Grüll H; Bratke G; Akuamoa-Boateng D; Baues C; Bos C; Verkooijen HM; Shukri A; Stock S; Müller D
Front Oncol; 2022; 12():987546. PubMed ID: 36212449
[TBL] [Abstract][Full Text] [Related]
2. Focused Ultrasound and RadioTHERapy for non-invasive palliative pain treatment in patients with bone metastasis: a study protocol for the three armed randomized controlled FURTHER trial.
Slotman DJ; Bartels MMTJ; Ferrer CJ; Bos C; Bartels LW; Boomsma MF; Phernambucq ECJ; Nijholt IM; Morganti AG; Siepe G; Buwenge M; Grüll H; Bratke G; Yeo SY; Blanco Sequeiros R; Minn H; Huhtala M; Napoli A; De Felice F; Catalano C; Bazzocchi A; Gasperini C; Campanacci L; Simões Corrêa Galendi J; Müller D; Braat MNGJA; Moonen C; Verkooijen HM;
Trials; 2022 Dec; 23(1):1061. PubMed ID: 36582001
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.
Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):556-63. PubMed ID: 25680599
[TBL] [Abstract][Full Text] [Related]
4. Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
Reddy D; van Son M; Peters M; Bertoncelli Tanaka M; Dudderidge T; Cullen E; Ho CLT; Hindley RG; Emara A; McCracken S; Orczyk C; Shergill I; Mangar S; Nigam R; Virdi J; Moore CM; Arya M; Shah TT; Winkler M; Emberton M; Falconer A; Belsey J; Ahmed HU
J Med Econ; 2023; 26(1):1099-1107. PubMed ID: 37656223
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of magnetic resonance-guided focused ultrasound ablation for palliation of refractory painful bone metastases.
Bucknor MD; Chan FP; Matuoka JY; Curl PK; Kahn JG
Int J Technol Assess Health Care; 2020 Dec; 37():e30. PubMed ID: 33267915
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of volumetric MRI-guided high intensity focused ultrasound (MR-HIFU) for painful bone metastases.
Huisman M; Lam MK; Bartels LW; Nijenhuis RJ; Moonen CT; Knuttel FM; Verkooijen HM; van Vulpen M; van den Bosch MA
J Ther Ultrasound; 2014; 2():16. PubMed ID: 25309743
[TBL] [Abstract][Full Text] [Related]
7. A time-driven activity-based costing approach of magnetic resonance-guided high-intensity focused ultrasound for cancer-induced bone pain.
Simões Corrêa Galendi J; Yeo SY; Simic D; Grüll H; Stock S; Müller D
Int J Hyperthermia; 2022; 39(1):173-180. PubMed ID: 35021942
[TBL] [Abstract][Full Text] [Related]
8. Combining radiotherapy and focused ultrasound for pain palliation of cancer induced bone pain; a stage I/IIa study according to the IDEAL framework.
Bartels MMTJ; Verpalen IM; Ferrer CJ; Slotman DJ; Phernambucq ECJ; Verhoeff JJC; Eppinga WSC; Braat MNGJA; van den Hoed RD; van 't Veer-Ten Kate M; de Boer E; Naber HR; Nijholt IM; Bartels LW; Bos C; Moonen CTW; Boomsma MF; Verkooijen HM
Clin Transl Radiat Oncol; 2021 Mar; 27():57-63. PubMed ID: 33532631
[TBL] [Abstract][Full Text] [Related]
9. Cost Effectiveness of External Beam Radiation Therapy versus Percutaneous Image-Guided Cryoablation for Palliation of Uncomplicated Bone Metastases.
Chang EM; Shaverdian N; Capiro N; Steinberg ML; Raldow AC
J Vasc Interv Radiol; 2020 Aug; 31(8):1221-1232. PubMed ID: 32674872
[TBL] [Abstract][Full Text] [Related]
10. Bone metastasis treatment using magnetic resonance-guided high intensity focused ultrasound.
Yeo SY; Elevelt A; Donato K; van Rietbergen B; Ter Hoeve ND; van Diest PJ; Grüll H
Bone; 2015 Dec; 81():513-523. PubMed ID: 26325304
[TBL] [Abstract][Full Text] [Related]
11. Economic Evaluation of Digital Therapeutic Care Apps for Unsupervised Treatment of Low Back Pain: Monte Carlo Simulation.
Lewkowicz D; Bottinger E; Siegel M
JMIR Mhealth Uhealth; 2023 Jun; 11():e44585. PubMed ID: 37384379
[TBL] [Abstract][Full Text] [Related]
12. 3-T magnetic resonance-guided high-intensity focused ultrasound (3 T-MR-HIFU) for the treatment of pain from bone metastases of solid tumors.
Bongiovanni A; Foca F; Oboldi D; Diano D; Bazzocchi A; Fabbri L; Mercatali L; Vanni S; Maltoni M; Bianchini D; Casadei C; Matteucci F; Nanni O; Rossi B; Sintuzzi E; Martoni ME; Zavoiu V; Barone D; Altini M; Ibrahim T
Support Care Cancer; 2022 Jul; 30(7):5737-5745. PubMed ID: 35332373
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of single-fraction versus multiple-fraction palliative radiotherapy for painful bone metastases in breast, lung and prostate cancer.
Collinson L; Kvizhinadze G; Nair N; McLeod M; Blakely T
J Med Imaging Radiat Oncol; 2016 Oct; 60(5):650-660. PubMed ID: 27174870
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
16. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Quality of Life Outcomes Following Palliative Treatment of Bone Metastases with Magnetic Resonance-guided High Intensity Focused Ultrasound: An International Multicentre Study.
Harding D; Giles SL; Brown MRD; Ter Haar GR; van den Bosch M; Bartels LW; Kim YS; Deppe M; deSouza NM
Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):233-242. PubMed ID: 29317145
[TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of focal high-intensity focussed ultrasound vs active surveillance for low- to intermediate-risk prostate cancer using a Markov multi-state model.
Bénard A; Duroux T; Robert G
BJU Int; 2019 Dec; 124(6):962-971. PubMed ID: 31298775
[TBL] [Abstract][Full Text] [Related]
19. Factors Influencing the Adoption of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Painful Bone Metastases in Europe, A Group Concept Mapping Study.
Simões Corrêa Galendi J; Siefen AC; Moretti DM; Yeo SY; Grüll H; Bratke G; Morganti AG; Bazzocchi A; Gasperini C; De Felice F; Blanco Sequeiros R; Huhtala M; Nijholt IM; Boomsma MF; Bos C; Verkooijen HM; Müller D; Stock S
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673840
[TBL] [Abstract][Full Text] [Related]
20. A cost-utility analysis of sacral anterior root stimulation (SARS) compared with medical treatment in patients with complete spinal cord injury with a neurogenic bladder.
Morlière C; Verpillot E; Donon L; Salmi LR; Joseph PA; Vignes JR; Bénard A
Spine J; 2015 Dec; 15(12):2472-83. PubMed ID: 26291400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
